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USING the  rat  b -cell  RIN-5AH  insulinoma  line  as  a
means for studying insulin-dependent diabetes melli-
tus  (IDDM),  it  is  shown  that  interleukin-1  (IL-1)
induces  b -cell  damage  initiated  by  early  apoptotic
signals. This action is demonstrated by DNA fragmen-
tation, as assessed by specific BrdU labeling, surface
expression of Fas and nitric oxide (NO) production.
In  addition,  the  interplay  between  NO  and  Fas  is
shown, while  scanning  electron  microscopy  (SEM)
confirms apoptosis by revealing the degree and type
of cellular damage which, in the case of IL-1a , can be
reversed by an inhibitor to NO synthesis. Apoptosis is
also  reconfirmed by  transmission  electron  micros-
copy (TEM) by observing condensed nuclear chroma-
tin after IL-1 exposure. Thus, treatment of insulinoma
cells with IL-1a and IL-1b seems to initiate a number
of  signals,  including  PKC  activation  as  published
previously, that ultimately lead to b -cell destruction.
Each  IL-1  isoform,  however,  definitely  follows  a
different pathway of action.
Key words: IDDM, IL-1, Apoptosis, Chromatin condensa-
tion, BrdU, Fas, Nitric oxide, PKC, Electron microscopy
Introduction
Insulin-dependent  diabetes  mellitus  (IDDM)  is  a
chronic  autoimmune  disease  characterized by  spe-
cific  destruction  of  insulin-secreting  b cells  of  the
pancreas.1,2 Pancreatic  Langerhans  islets  are  com-
posed  of  a  heterogeneous  population  of  secretory
cells (a and b cells) as well as non-endocrine cells
(macrophages, endothelial cells,  dendritic cells and
fibroblasts).3The presence of such a variety of cellular
components  renders  the  investigation  of  causes
leading to b cell destruction extremely difficult and,
although studies on IDDM started decades ago,4 the
exact  pathway(s)  from  insulitis  to  the  end-stage
disease still remains unknown.5–7
Recent studies, however, have led to the formulation
of hypotheses8,9 giving clues on how the disease starts,
develops and  progresses.  One  major finding  is  the
ability of non-endocrine cells, mainly activated macro-
phages, natural killer (NK) cells, as well as B and T
lymphocytes, to produce diverse cytokines like inter-
leukin-1 (IL-1a , IL-1b ), tumor necrosis factor-a (TNF-a )
and  interferon-g (IFN-g ).11–13 These  cytokines have
been shown to induce b cells to undergo a number of
events like production of NO14,15 and elevation of class
II  major  histocompatibility  complex  (MHC)  anti-
gens.15–17 They also interact with each other without
excluding  their  potential  synergist  tendency  with
transforming growth factor-1b (TGF-1b ).18
The  present  work  aims  at  the  cellular  events
leading  to  b cell  damage  by  IL-1,  the  possible
delineation of the pathway(s) followed by this media-
tor and the possible reversibility  of  the destructive
action which may be of value in the future. By thus
employing  the rat b -insulinoma  cell  system of RIN-
5AH19 as a model for IDDM, since these cells show in
vitro what can happen to normal b cells in vivo, it is
shown by  apoptotic studies (BrdU  labeling  and Fas
expression),  intermediate  product  assessment  (NO,
PKC) and electron microscopy (SEM, TEM) that the
degree of cell damage detected is neither the same
nor similarly regulated by the two cytokines. How-
ever,  in  the  case  of  IL-1a ,  it  can  be  ultimately
reversed.
Therefore, it appears that IL-1-induced apoptosis of
b -cells  is  a  multi-stage  process  dependent  upon  a
number of parameters, and that each isoform follows
differently regulated pathways of action.
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Cells and culture
The b cell-like line RIN-5AH used in this study was
provided by Dr Herbert Oie.19 Cells were grown in
plastic culture flasks (Flow) in DMEM (Gibco) supple-
mented with 10% fetal bovine serum (FBS; Gibco) and
maintained at 37°C in 5% CO2 atmosphere.
IL-1 reagents and induction protocol
Human recombinant IL-1a and -b were generous gifts
from Dr Steven Gillis of Immunex Corp. (Seattle, WA),
and used at concentrations of 12.5 and 25ng/ml of
culture, respectively. IL-1a and -b preparations from
NCI  (Mc  Kesson  BioServices,  Rockville,  MD)  were
also used at the same protein concentrations and gave
similar  results.  In all  but  the BrdU  labeling  experi-
ments, the cells were incubated with the above-stated
amounts of IL-1 for 48h. For the BrdU labeling, IL-1
exposure was for 2–8h only in order to determine the
presence of early  apoptotic signals.  In  experiments
where  inhibitors  were  involved  (inhibition  of  NO
release),  the  iNOS  inhibitor  aminoguanidine  (AG;
Sigma)  was  added in  the culture  18h prior  to IL-1
exposure.
Other reagents
The  Fas  affinity-purified  rabbit  polyclonal  antibody
was purchased from  Santa Cruz  (CA) and used  for
surface labeling  at  a  concentration of 1m g/ml. The
BrdU labeling kit for DNA fragmentation assessment
was  purchased  from  Boehringer  Mannheim  (Ger-
many)  and  used  according  to  the  manufacturer’s
instructions (see below). Antibodies to different PKC
isoforms  were  purchased  from  Transduction  Labo-
ratories (Lexington,  KY)  and used at the suggested
concentration by the supplier (1m g/test). Also from
the  same  source  were  the  specific  antibodies  to
inducible-  and  endothelial-NOS  (i-  and  e-NOS)  sim-
ilarly used at 1m g/test. Aminoguanidine (AG), a NOS
inhibitor, was bought from Sigma (St Louis, MO) and
used at 0.5mM. Finally, all reagents for NO measure-
ment  (sulfanilamide  and  naphthylethylenediamine
dihydrochloride) were also purchased from Sigma.
NO measurement
Accumulation of NO in the medium of the IL-1-treated
RIN cells was estimated by the determination of the
concentration  of  the  stable  oxidation  end-product
nitrite by an automated colorimetric assay based on
the Griess reaction as previously described.15 Nitrite
concentrations  were  calculated  by  comparison  to
sodium nitrite standards.
Immunofluorescence
IL-1-induced RIN cells were processed for surface Fas
expression as previously described,15 whereas cyto-
plasmic PKC as well as i- and e-NOS detection was
performed by first permeabilizing the cells and then
proceeding as in the case of surface staining.20
BrdU labeling
This assay has been applied to measure apoptosis by
detection  of  BrdU-labeled  DNA  fragments  in  the
cytoplasm of affected cells and/or necrosis by deter-
mining  the  amount  of  the  same  BrdU-labeled  DNA
fragments that have been released from the damaged
target cells into the culture supernatants. It is based
on the quantitative sandwich enzyme ELISA principle
using  two  monoclonal antibodies against  DNA and
BrdU and was done using Boehringer’s # 1 585 045 kit
for cellular  DNA  fragmentation. Briefly,  anti-DNA is
fixed in 96-well plates where 2 3 103 cells/well are
added for the culture conditions already mentioned.
After BrdU addition, the BrdU-labeled DNA fragments
found  in  the test samples bind to  the immobilized
anti-DNA antibody and then the immunocomplexed
fragments are denatured and fixed on the surface of
the wells by microwave irradiation. Finally, anti-BrdU
peroxidase conjugate reacts with the BrdU incorpo-
rated into the DNA and, after removing the unbound
peroxidase conjugates, the amount of the complexed
peroxidase  is  determined  photometrically  at
370–492nm  using  3,39 ,5,59 -Tetramethylbenzidine
(TMB) as a substrate.
Scanning electron microscopy (SEM)
For the SEM experiments, RIN-5AH cells were placed
in 24-well plates (Sarstedt, Newton, NC) and cultured
as described above with all the possible combinations
of IL-1 and/or AG. In order to avoid cell damage by
scraping, each well contained, at its bottom, a 13-mm
diameter tissue culture coverslip (Sarstedt) which was
simply  removed  for  further  processing.  Thus,  the
adherent  cells  on  the  coverslip  were  fixed  in  1%
paraformadehyde  and  1%  glutaraldehyde  in  0.14M
sodium cacodylate buffer for 3h. To preserve plasma
membrane integrity, the cells were postfixed in 1%
osmium tetroxide (OsO4) containing 0.1% ruthenium
red  in  0.14M  cacodylate buffer  for  1h  at  4°C. All
samples  were  dehydrated  through  an  ascending
ethanol series, critical point dried and coated with
approximately 2nm of platinum. The samples were
examined  in  a JEOL  (Tokyo,  Japan)  SEM  at various
magnifications and scanned accordingly.
Transmission electron microscopy (TEM)
For TEM analysis, RIN-5AH cells were fixed in 2.5%
glutaraldehyde  in  5%  sucrose  in  0.2M  cacodylate
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Then  the  samples were postfixed  in  1% OsO4,  5%
sucrose and 0.1% ruthenium red for 2h at 4°C. After a
complete  dehydration  through  a  graded  series  of
alcohol solutions, the cell pellets were embedded in
L.R. White resin. Embedded samples were sectioned
with  an  LKB  Ultratome-V.  Sections  of  50–60m m
thickness were collected on 300-mesh  nickel grids,
quickly washed in PBS, and then washed in 1% BSA in
PBS  for  10min.  Images  were  obtained  on  Kodak
electron microscope film 4489, using the JEOL-100C
electron microscope, operated at 80kV.
Statistical analysis
In order to evaluate the statistical significance of the
values between test samples and controls, all experi-
ments were performed at least four times in triplicate,
and the Student’s t-test was employed for the assess-
ment of significance levels (P).
Results
Demonstration of cell death by DNA
fragmentation (BrdU incorporation)
In order to investigate cell death due to IL-1 exposure,
BrdU  incorporation  was  assessed  48h  after  IL-1
addition to RIN cells. The results showed (Fig.  1A)
that after 2 days the cells presented a necrotic state.
However, this action, although statistically significant
(P<0.02),  was  not  convincing  since  after  48h  of
culture  many  events  could  have  taken  place  and
necrosis could have been the final event, thus missing
possible  earlier  stages  of  apoptosis.  Therefore,  in
order to exactly pinpoint the effect of IL-1a and IL-1b
on these cells, we chose to repeat the experiments at
earlier culture stages, that is at 2, 4, 6 and 8h of IL-1
exposure. This  approach  permitted  to  demonstrate
that both IL-1a and IL-1b initiated an early apoptotic
signal,  as  detected by  cytoplasmic  DNA fragmenta-
tion,  that  was  maximal  4h  after  cytokine  addition
(Fig. 1B,C). When both interleukins were added to the
cells simultaneously, a lower in magnitude apoptotic
signal was seen at an even earlier time (2h) which,
however, was lost beyond 4h of exposure (Fig. 1D).
Thus, IL-1 appears to deliver early apoptotic signals to
the  b -insulinoma  cells  that will  eventually  lead  the
cells to their death. Thus, the necrotic signal obtained
from the fragmented DNA in the culture supernatants
at 48h of IL-1 addition to the cells (as shown above;
Fig. 1A) appears to be a normal consequence.
Demonstration of cell death by assessing Fas
expression and its correlation to NO
production
Expression of Fas has been defined as an apoptotic
marker8,  whereas  cells  expressing  Fas-L  have  been
reported  to  promote  cell  death/apoptosis  of  Fas-
bearing target cells when both populations come into
contact.8,9 Regardless of the constitutive or induced
expression  of  Fas  and/or Fas-L, the  above  situation
applies in vivo where diverse cellular populations are
present  and  interacting  with  each  other.  In  vitro,
however, the homogeneous cell populations used do
not provide the matrix for cellular interactions that
will facilitate or reproduce the in vivo situation. Thus,
determination of the presence or absence of Fas is
crucial since it may give clues as to whether presence
or induction of this marker may account, by extrap-
olation,  for  cellular  death  in  the  living  organism.
Therefore,  it  was  investigated  whether  IL-1  could
induce Fas expression on the rat RIN cell line as it
does with human and murine b cells.9,10 After 48h of
culture, both IL-1a and IL-1b could induce significant
levels of surface Fas expression over control (P<0.001
in both cases) suggesting its participation in apoptotic
interactions (Fig. 2).
Cell  death  in  IDDM  has  been  linked  to  other
mechanisms as well, one of which is production of
NO (reviewed in Refs. 10 and 21). IL-1a and IL-1b do
induce significant amounts of NO15,22,23 which can be
ablated by the NOS inhibitor aminoguanidine (AG),24
that was found in our laboratory to be more potent
than other inhibitors tested (L-NAME and L-NMMA;25
data  not  shown).  It  thus  became  obvious  to  ask
whether Fas and NO are related in their final task of
cell death. For this, using the same NOS inhibitor, AG,
IL-1-induced apoptosis in IDDM
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FIG.  1.  Apoptosis  vs  necrosis  on  RIN-5AH  cells  after  IL-1
exposure. (A) IL-1a and IL-1b after a 48-h treatment; (B) IL-1a
at earlier times; (C) IL-1b at 2, 4, 6 and 8h; (D) Combination of
IL-1 isoforms.Fas expression was reassessed. It was found that, in
the  case  of  IL-1a ,  AG  was  unable  to  inverse  the
induction  of  Fas,  whereas in  the  case of IL-1b the
inhibition was statistically significant  (P<0.001;  Fig.
2), suggesting a link between these two intermediates
in IL-1b but not IL-1a induction.
Assessment of the differential pathway of NO
induction in RIN-5AH cells after IL-1 exposure
In order to explain and further examine the causes of
the  above-stated difference  in  Fas  inhibition  by AG
after IL-1a and IL-1b induction, it was hypothesized
that IL-1a and IL-1b could regulate NO production by
different  means. To  study  this  possibility,  immuno-
fluorescence experiments with specific i- and e-NOS
antibodies  were  performed. The  results  in Table  1
show that, in  the case of  IL-1a ,  only  the inducible
form of NOS is activated leading to NO production,
whereas in the case of IL-1b both i- and e-NOS are
triggered. This latter observation ascribes to IL-1b the
ability  to  lead  RIN  cells  towards  endothelial  cell
differentiation, a property not at all improbable, since
IL-1’s  differentiation-inducing  capacity  on  different
cellular  systems  has  been  well  described.26 Such
differential activation of the NOS isoforms by IL-1a
and  IL-1b (only  i-NOS  versus  dual  i-  and  e-NOS,
respectively),  however,  may  also  account  for  the
relationship and/or regulation between IL-1-induced
NO  and  IL-1-induced  Fas.  It  may  explain  why AG,
although inhibiting IL-1a - and IL-1b -induced NO, only
inhibits the IL-1b -induced Fas expression and not that
of the IL-1a as shown in Fig. 2.
Demonstration of cell death by scanning
electron microscopy
In order to assess the degree of cell damage as well as
the  reversibility  of  this  effect,  scanning  electron
microscopy was employed.
IL-1a
Using the same 48-h IL-1 induction protocols with or
without  aminoguanidine,  it  was  seen  that  IL-1a
destroyed  the  cells  by  opening  holes  and  creating
deep cuts by a degree greater than 65 and approach-
ing 80% (Fig. 3C). This effect was completely ablated
by aminoguanidine (by 85%; Fig. 3D) returning the
cells to their initial appearance (Fig. 3A,B).
Therefore,  since  aminoguanidine  (1)  moderately,
but significantly, inhibits IL-1a -induced NO (P<0.02;
data not shown) and (2) does not block IL-1a -induced
Fas, it appears that Fas and NO are two independent
events. Their individual and indisputable involvement,
however,  in  cell  destruction  does  not  apparently
follow the same pathway. The link and the major point
from  these results, in conjunction with the finding
that  aminoguanidine  inhibits  IL-1a -induced  cellular
damage (as seen by SEM in Fig. 2D), is that only NO
via  i-NOS  (Table  1)  and  not  Fas  seems  to  actively
participate in IL-1a -induced apoptosis. As a note of
caution,  however,  the  role  of  IL-1a -induced  Fas
cannot  be  underestimated  since,  as  an  apoptotic
candidate molecule, it must be always considered as a
causative agent acting in as yet undetermined ways
(see Discussion for the possible interplay between Fas
and protein kinase C).
IL-1b
IL-1b gave different results, at least optically. Exposure
of RIN cells to IL-1b revealed more swollen and hairy-
like  cells  (by  70%)  that  had  no  apparent  surface
damage (Fig. 3E). This swollen type that results from
the swelling of organelles, however, has been descri-
bed as evidence of apoptosis,27 which will eventually
lead to cell rupture. Thus, since we obtain apoptotic
signals by DNA fragmentation (Fig. 1C), and apoptotic
nuclei by transmission electron microscopy (TEM; see
below), it seems that indeed this unusually  swollen
appearance  is  indicative  of  apoptosis. Aminoguani-
dine  could  not  alter  anything  of  the  IL-1b action
morphologically (Fig. 3F).
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FIG. 2. Ability of IL-1a and IL-1b to induce Fas expression and
reversibility by the NOS inhibitor aminoguanidine (AG).
Table 1. Differential induction of i- and e-NOS by IL-1a and IL-
1b on RIN-5AH cells
Net
a percent (±SEM) of:
Anti-i-NOS Anti-e-NOS
IL-1a 13 ± 1 1 ± 1
IL-1b 5 ± 1 7 ± 2
a As assessed by immunofluorescence and by subtracting the control
(untreated)  staining  which  for  both  i-  and  e-NOS  was  2  ±  1%.
According  to  this  negative  control  value, all percentages  obtained
(except the IL-1a -induced e-NOS) were statistically significant.Therefore, since AG totally inhibits  IL-1b -induced
NO (P<0.001; data not shown) and IL-1b -induced Fas
(Fig.  2),  it  can  be  claimed  that  Fas  and  NO  are
probably two linked events when induced by this IL-1
isoform,  and  that  their  relationship  is  found,  as
derived from Table 1, perhaps at the level of e-NOS
regulation. However, since AG does not influence IL-
1b cellular morphology, it can be cautiously claimed
that neither Fas nor NO participate in the apoptotic
event  initiated  by  IL-1b ,  but  they  follow  other
pathways in order to exercise their known destructive
role on the RIN pancreatic population.
The  combination  of  both  IL-1  preparations  gave
mixed results (data not shown), where the separate
effects of each IL-1 were seen combined at a degree
greater  than  70%.  The  addition  of  AG  did  not
restore the cellular damage, a rather expected result
if one considers the multiplicity  of the possibilities
as  described  above  for  each  IL-1  isoform
separately.
IL-1-induced apoptosis in IDDM
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FIG. 3. Scanning electron microscopy of RIN-5AH cells treated with: (A) PBS at a magnification of 3 3300; (B) aminoguanidine
at 3 3500; (C) IL-1a at 3 2000; (D) IL-1a +aminoguanidine at 3 2500; (E) IL-1b at 3 2000; (F) IL-1b +aminoguanidine at 3 2000.Demonstration of cell death by transmission
electron microscopy
For further ascertaining apoptosis, transmission elec-
tron  microscopy  was  employed.  Using  the  same
experimental protocol of induction with IL-1 and the
exact  same  timing  as  in  the  case  of  the  scanning
experiments (see above), the nuclei of the RIN cells
were observed. The aim was to ascertain whether IL-1
could cause chromatin condensation, an indication of
the apoptotic nucleus.28–30 It was seen that, although
aminoguanidine alone (not shown) did not affect the
nuclear  appearance,  both  IL-1  preparations  caused
some degree of chromatin condensation. This effect is
marked by the presence of heterochromatin, which is
transcriptionally inactive DNA, that tends to pack at
the  inner  surface  of  the  nuclear  membrane.  This
situation could be reversed by AG only in the case of
IL-1a (approximately 80–85%) and not in the case of
IL-1b .  Representative  images  (Fig.  4A,B)  show  the
combination  of  IL-1a with AG  (without  chromatin
condensation; reversal of effect) and IL-1b +AG (with
presence of condensed chromatin).
Discussion
IL-1-induced apoptosis in IDDM
This work has shown that IL-1 induces early apoptotic
signals to the b -insulinoma RIN-5AH cells that have
been used as a model of IDDM, since the study of
those cells in vitro is indicative of what happens to
normal b cells in vivo. This early  action is accom-
panied by a number of other events, some of which
have  also  been  studied  here.  These  include  DNA
fragmentation,  NO  production  and  Fas  up-
regulation.
Depending on the IL-1 isoform, it can been seen
that the way the intermediates behave towards cell
destruction differs enormously:
First, in IL-1a -induced apoptosis, NO is shown to
actively participate/synergize in the final task of cell
death,  whereas  the  role  of  Fas  seems,  although
documented and widely accepted,9,10 independent of
IL-1a . An important point of great interest and with
future implications is the reversibility of cell damage
by aminoguanidine.
Second,  concerning  IL-1b -induced  apoptosis,
although NO and Fas seem to proceed together to
their destructive role, since they appear to be  two
linked events, neither convincingly  synergizes with
IL-1b .
This differential behavior in apoptosis in terms of
cellular  appearance and regulation  of  intermediates
followed by the two IL-1 isoforms was not, however,
unexpected. Our laboratory has shown that IL-1a and
IL-1b binding  on  specific  and,  at  the  same  time,
distinct surface receptors on these very  same cells
follows  different  kinetics.15 In  addition, the  signals
transduced via these receptors for the induction of
surface class II histocompatibility antigens, and prob-
ably for other regulatory molecules, have also been
demonstrated to be different.15,20
The  majority  of  the  results  presented  here  on
apoptosis are in agreement with the works of many
laboratories, as presented in a recent review article by
Mauricio and Mandrup-Poulsen.27 However,  it must
be  noted  that  most  of  the  work  done  on  IDDM
concerns the actions of IL-1b and not that of IL-1a .
This  is  probably  due  to  the  controversial  results
usually obtained with IL-1a . This fact can be explained
by the presence of not uniformly  and continuously
up-regulated IL-1a receptors15 on b cells that, accord-
ing to their density at the time of the experiments,
seem  capable  of  transducing  different  signals,  as
mentioned already.
Is there any PKC involvement in IL-1-induced
cellular damage?
According to a recent publication by Wang et al.,31 it
is  suggested  that  in  a  variety  of  cellular  systems
PKC regulates Fas expression. In addition, we have
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FIG. 4. Transmission electron microscopy of RIN-5AH cells
treated with: (A) IL-1a +AG where no condensed chromatin is
obtained;  3 20000;  (B)  IL-1b +AG  with  condensed  nuclear
chromatin;  3 13000  (N,  nucleus;  nm,  nuclear  membrane;
c, cytoplasm).previously  published that IL-1a induces the expres-
sion of PKC on the RIN-5AH cells by a significant net
percentage of 30%, as assessd by a pan-PKC mono-
clonal antibody (Upstate Biotechnology, Lake Placid,
NY). On the contrary, IL-1b can only trigger the cells
to  express  a  non-significant  net  5%  (5+1%  in  the
untreated control, 35+6% with IL-1a and 10+1% with
IL-1b ).20
From the present work it can be seen that IL-1a
induces a significant amount of Fas (Fig. 2), while it is
also  able  to  induce  a  significant  amount  of  total
PKC.20 On the other hand, IL-1b , which triggers the
cells to marginally express total PKC,20 induces the
same  levels  of  Fas  compared  to  IL-1a (Fig.  2).
Although  these  results  are  not  exactly  compatible,
unpublished  data  from  our  laboratory  have  shown
that the constitutive PKCa expression of RIN cells can
be blocked by IL-1b (from 22 to 4%; P<0.001), while
PKCb is  augmented from  0  to 8%  (P<0.02),  the  µ
isoform  is  marginally  increased  from  0  to  3%
(P <0.25), PKCz remains unaffected (4–6%) and the e
isoform decreases from 4 to 0% (P<0.25). While all
other PKC isoforms are not expressed on untreated
RIN cells, and not modulated by at least IL-1b , it is
possible that there exists an intracellular cooperation
between  Fas  and  total  or  isoform-specific  PKC,  in
conjunction  with  cellular  damage  initiated  by  IL-1.
Such a possibility can be examined by the use of PKC
inhibitors  (i.e.  sphingosine  at  50m M20),  since  this
approach  may  give  answers  to  these  and  other
relevant  questions,  currently  investigated  by  our
laboratory.
Thus, from the present study, it is apparent that IL-
1a and IL-1b follow their own regulatory pathway(s)
concerning  b -cell  damage.  Regardless,  however,  of
the  IL-1  isoform  or  any  other  cytokine/mediator
employed, the study  of  b -cell  destruction in  IDDM
remains a difficult task to pursue, since the number of
intermediates involved indicate the complexity of the
cellular interactions leading to cell death.
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